HUBS vs REPL · P/E 96, rev $2.63B vs $825.7M cap
HubSpot Inc (HUBS) versus Replimune Group Inc (REPL) — a side-by-side from cached financials, not a winner call.
HubSpot Inc (HUBS) is a software - application company listed on NYSE.
Replimune Group Inc (REPL) is a biotechnology company listed on NASDAQ.
Latest reported HUBS revenue for 2024-12-31 was $2.63B. Net income was $4.6M. Revenue was up 21.1% from 2023-12-31 to 2024-12-31. HUBS currently screens at market cap $9.36B and trailing P/E 96.2.
REPL does not have a complete income-statement cache yet.
HUBS currently screens at market cap $9.36B and trailing P/E 96.2. REPL currently screens at market cap $825.7M.
Not investment advice. Open the HUBS and REPL stock pages for the full models.
Not investment advice.